金吾财讯 | 思泰瑞医疗（STE）宣布，其全资子公司已与手术用品公司Xodus Medical达成最终协议，将以21亿美元的总价收购后者。该笔交易预计主要通过债务融资完成，将在2026年12月31日前完成交割。据介绍，本次并购预计将产生约3亿美元的税收优惠（净现值约3亿美元），扣除后实际净收购价格约为18亿美元。此外，若Xodus Medical达成指定的业绩目标，其还可能在2028年获得最高1.5亿美元的或有对价支付。Xodus Medical预计将在2026年实现约2.45亿美元的营收及1.35亿美元的调整后EBIT（息税前利润）。思泰瑞医疗表示，将在交易完成后更新其2027财年业绩指引。思泰瑞医疗总裁兼CEO丹·卡雷斯蒂奥指出，Xodus的产品线是对公司现有业务的极佳补充，尤其能显著增强思泰瑞医疗在手术室安全耗材领域的市场地位。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.